SHANK3 and schizophrenia: Proteomic and genomic evidence involving PSD-associated proteins and genes implicated in schizophrenia showed altered differentially expressed NMDA-interacting proteins, such as Shank3, known to contribute to the pathophysiology of the disease [69].